These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The new generation of serotonergic anxiolytics: possible clinical roles. Eison MS Psychopathology; 1989; 22 Suppl 1():13-20. PubMed ID: 2567037 [TBL] [Abstract][Full Text] [Related]
4. Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers. Naranjo CA; Sellers EM Recent Dev Alcohol; 1989; 7():255-66. PubMed ID: 2522667 [TBL] [Abstract][Full Text] [Related]
5. Modulation of ethanol intake by serotonin uptake inhibitors. Naranjo CA; Sellers EM; Lawrin MO J Clin Psychiatry; 1986 Apr; 47 Suppl():16-22. PubMed ID: 3007443 [TBL] [Abstract][Full Text] [Related]
6. Serotonin uptake blockers and the treatment of alcoholism. Gorelick DA Recent Dev Alcohol; 1989; 7():267-81. PubMed ID: 2648494 [TBL] [Abstract][Full Text] [Related]
7. Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies. Gill K; Amit Z Recent Dev Alcohol; 1989; 7():225-48. PubMed ID: 2648493 [TBL] [Abstract][Full Text] [Related]
8. Animal models for anxiety and response to serotonergic drugs. Broekkamp CL; Berendsen HH; Jenck F; Van Delft AM Psychopathology; 1989; 22 Suppl 1():2-12. PubMed ID: 2567038 [TBL] [Abstract][Full Text] [Related]
9. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism. Lejoyeux M Alcohol Alcohol; 1996 Mar; 31 Suppl 1():69-75. PubMed ID: 8737004 [TBL] [Abstract][Full Text] [Related]
10. Serotonin-influencing drugs in the treatment of panic disorder. Westenberg HG; den Boer JA Psychopathology; 1989; 22 Suppl 1():68-77. PubMed ID: 2498967 [TBL] [Abstract][Full Text] [Related]
11. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism. Lejoyeux M Alcohol Alcohol Suppl; 1996 Mar; 31(1):69-75. PubMed ID: 9845041 [TBL] [Abstract][Full Text] [Related]
12. 5-HT receptors: implications for the neuropharmacology of alcohol and alcoholism. Overstreet DH; Rezvani AH; Pucilowski O; Janowsky DS Alcohol Alcohol Suppl; 1994; 2():205-10. PubMed ID: 8974337 [TBL] [Abstract][Full Text] [Related]
13. [Alcohol and the serotonin system]. Daoust M; Ernouf D; Narcisse G Ann Med Psychol (Paris); 1992; 150(2-3):143-6. PubMed ID: 1343508 [TBL] [Abstract][Full Text] [Related]
14. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data. LĂȘ AD; Tomkins DM; Sellers EM Alcohol Alcohol Suppl; 1996 Mar; 31(1):27-32. PubMed ID: 9845035 [TBL] [Abstract][Full Text] [Related]
15. Serotonergic Systems in the Pathophysiology of Ethanol Dependence: Relevance to Clinical Alcoholism. Marcinkiewcz CA ACS Chem Neurosci; 2015 Jul; 6(7):1026-39. PubMed ID: 25654315 [TBL] [Abstract][Full Text] [Related]
16. Use of serotonin-active drugs in alcohol preference studies. Zabik JE Recent Dev Alcohol; 1989; 7():211-23. PubMed ID: 2648492 [TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine and alcoholism. Thomas R Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():85-90; discussion 90-2. PubMed ID: 1806637 [TBL] [Abstract][Full Text] [Related]
18. The antidepressant effects of 5-HT uptake inhibitors. Aberg-Wistedt A Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638 [TBL] [Abstract][Full Text] [Related]
19. A nonhuman primate model of excessive alcohol intake. Personality and neurobiological parallels of type I- and type II-like alcoholism. Higley JD; Linnoila M Recent Dev Alcohol; 1997; 13():191-219. PubMed ID: 9122496 [TBL] [Abstract][Full Text] [Related]